FDA Approves Journavx Drug to Treat Pain Without Addiction Risk NYT Par : Gina Kolata 31 janvier 2025 à 01:12 The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. © Lucas Jackson/ReutersThe drug was tested in two large clinical trials, each with approximately 1,000 patients who had pain from surgery. In one, patients had an abdominoplasty, or tummy tuck; in the other, a bunionectomy.
R.F.K. Jr., in His Own Words: Flu, Diabetes, Autism and More NYT Par : Apoorva Mandavilli and Jamie Leventhal 28 janvier 2025 à 19:50 Robert F. Kennedy Jr., President Trump’s nominee for health secretary, doesn’t just hold fringe views on vaccines. We fact-checked five recent statements.